Search the Newsreel

Summit Global Investments Makes New Investment in Customers Bancorp, Inc $CUBI

Omeros Corporation (NASDAQ:OMER) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Omeros Corporation (NASDAQ:OMER) has received a "Moderate Buy" consensus recommendation from brokerages, with an average 12-month price target of $38.00, significantly higher than its recent share price of $17.19. The company recently exceeded Q2 earnings expectations, reporting $0.02 EPS against an anticipated $0.27 loss, …

Did Slower Net Interest Income Growth Just Shift Customers Bancorp's (CUBI) Investment Narrative?

Analysts are questioning Customers Bancorp's (CUBI) investment narrative due to slower net interest income growth and a low net interest margin compared to peers. The bank's earnings per share have not kept pace with revenue, raising concerns about its ability to convert growth into …

Atomera (ATOM) Stock Forecast & Analyst Ratings

This document appears to be a placeholder or an incomplete article focusing on Atomera (ATOM) stock forecast and analyst ratings. No substantive content is provided beyond the title.

Omeros: YARTEMLEA Is Off To A Blistering Start (NASDAQ:OMER)

Omeros Corporation has received a Buy rating due to YARTEMLEA's unexpectedly strong launch, generating $28.5 million in net sales and positive operating cash flow in its first full quarter. The drug's adoption is rapidly increasing across transplant centers, with high formulary approval rates and …

Omeros Corporation $OMER Shares Purchased by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP significantly increased its stake in Omeros Corporation (NASDAQ:OMER) by 85.2% in the first quarter, now holding 179,594 shares valued at $1.9 million. This comes as Omeros recently reported strong Q2 earnings, beating analyst expectations with $0.02 EPS and $28.53 million …

Omeros (OMER) Stock Jumps On YARTEMLEA Profit Breakthrough

Omeros Corp Swings To Q2 Profit On YARTEMLEA Momentum; Plans ARDS, TA-TMA Studies; Shares Rise

Omeros Corporation reported a swing to profit in Q2 2026, driven by significant revenue growth from its YARTEMLEA sales. The company also announced plans to initiate two new studies for YARTEMLEA by the end of 2026, targeting hyperinflammatory acute respiratory distress syndrome (ARDS) and …

OMEROS CORP SEC Filing (Aug 13, 2026)

This article details an SEC Form 144 filing by Omeros Corp (OMER) on August 13, 2026. The filing indicates a proposed sale of 5,000 shares of common stock, valued at $68,550.00, resulting from the exercise of stock options. The shares are to be sold …

Top trending stocks today: ARX, OMER, TMS lead the market movers

Accelerant Holdings (ARX), Omeros Corporation (OMER), and Teamshares Inc. (TMS) were among the top trending stocks, experiencing significant surges due to major news or earnings momentum. Accelerant Holdings saw a 43.2% jump after an announced all-cash buyout, Omeros Corporation rose 24.5% following impressive Q2 …

Customers Bancorp Inc stock hits all-time high at 84.05 USD

Customers Bancorp Inc (CUBI) stock has reached an all-time high of $84.05, demonstrating a robust performance with a 25.67% increase over the past year and 13.22% year-to-date gains. Despite being considered overvalued by InvestingPro data, analysts have revised earnings estimates upward, and the company …

Omeros Corp Swings To Q2 Profit On YARTEMLEA Momentum; Plans ARDS, TA-TMA Study; Shares Rise

(RTTNews) - Omeros Corporation (OMER), a commercial-stage biotechnology company, on Wednesday reported second-quarter 2026 results that turned to profit, compared with a loss last year, aided by revenue growth driven by YARTEMLEA sales. In addition, the company provided an update on its development pipeline. …

Omeros outlines Q3 2026 interest expense of about $6.5M while advancing $287,000 NTAP for YARTEMLEA

Earnings Call Insights: Omeros Corporation (OMER) Q2 2026 MANAGEMENT VIEW * "YARTEMLEA generated $32.2 million in gross sales in its first full quarter on the market," "operations generated $4.1 million of positive cash flow during the quarter," and "we meaningfully strengthened our capital structure …

Somerset Minerals (ASX:SMM) Shares in Focus, Talisker Drilling Confirms Copper-Silver Discovery

Omeros (NASDAQ:OMER) Releases Earnings Results, Beats Estimates By $0.29 EPS

Customers Bancorp, Inc. (CUBI) Stock Price, News, Quote & History

Omeros Corporation reports results for the quarter ended June 30 - Earnings Summary

Omeros Corporation has released its earnings summary for the quarter that ended on June 30. The article, sourced from Reuters, provides a concise overview of the company's financial performance during this period. Readers can access the full report for detailed insights into the results.

Omeros (OMER) Q2 Earnings and Revenues Beat Estimates

Omeros Corporation (NASDAQ: OMER) turns profitable as YARTEMLEA sales ramp

Omeros Corporation (NASDAQ: OMER) reported a significant return to profitability in Q2 2026, driven by $28.5 million in product sales from its newly launched drug YARTEMLEA. The company achieved a net income of $13.2 million for the quarter and $69.3 million for the first …

Omeros surges 13% on strong earnings and revenue beat

Omeros Corporation (NASDAQ:OMER) reported second-quarter results that significantly surpassed analyst expectations, driven by strong sales of its new TA-TMA treatment, YARTEMLEA. The company posted adjusted earnings per share of $0.02 and revenue of $28.5 million, significantly beating estimates. Shares of Omeros surged 13% in …

OMEROS ($OMER) Releases Q2 2026 Earnings, Stock Rises

Mirgor Sociedad Anónima, Comercial, Industrial, Financiera, Inmobiliaria y Agropecuaria presenta sus resultados del segundo trimestre y del primer semestre de 2026

BRIEF-Omeros Corporation Q2 EPS USD 0.18

Omeros Corporation reported Q2 EPS of USD 0.18. This brief announcement was made available via Reuters and highlighted on TradingView News.

Earnings Flash (OMER) Omeros Corporation Reports Q2 Revenue $28.5M, vs. FactSet Est of $12.7M

Omeros Corporation (OMER) announced Q2 revenue of $28.5 million, significantly surpassing FactSet's estimate of $12.7 million. The company, which is a clinical-stage biopharmaceutical firm, focuses on developing therapeutics for complement-mediated diseases, cancers, and addictive disorders. They also reported earnings results for the second quarter …

Agencia Comercial Spirits Signs US$10 Million, Five-Year Networking Deal to Advance Indonesia AI Infrastructure

Agencia Comercial Spirits Ltd. has signed a five-year, US$10 million networking integration services agreement to support its AI computing infrastructure deployment in Indonesia. This deal provides network access and ongoing maintenance for the platform, scaling Agencia’s AI business alongside its whisky operations. However, management …

Agencia Comercial Spirits (AGCC) commits $10M to 5-year AI networking build in Indonesia

Somerset Minerals Director Increases Stake via Entitlement Offer

Somero Plans Virtual Investor Presentation Following Half-Year Results

Atomera (ATOM) Q2 2026 Earnings Call Transcript

Atomera (ATOM) reported its Q2 2026 earnings, detailing advancements in gate-all-around (GAA) technology with a key customer, expanded opportunities in NAND flash memory, and a significant breakthrough in GaN-on-silicon for RF applications. The company saw revenue of $158,000, a GAAP net loss of $6.3 …

Somerset Minerals Issues 26.8 Million Unquoted Long-Dated Options

Somerset Minerals Seeks ASX Quotation for 53.7 Million New Shares

Somerset Minerals Raises Full Entitlement Offer and Shortfall Funding

Sociedad Comercial del Plata S.A. presenta sus resultados del segundo trimestre y del primer semestre de 2026